Abnorme uterine Blutungen

• Literatur

• 1 Emons G, Gudermann T, Hinney B et al. Gynäkologische Endokrinologie. In: Deutsche Gesellschaft für Endokrinologie Hrsg. Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Stuttgart, New York: Georg Thieme Verlag; 2010: 270-303
• 2 Ludwig M. Amenorrhö und andere Zyklusstörungen – Differenzialdiagnostik und Therapie. Frauenheilkunde up2date 2011; 5: 153-163
• 3 Endrikat J, Vilos G, Muysers C et al. The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia. Arch Gynecol Obstet 2011; 1: 1-1 [in press]
• 4 Marret H, Fauconnier A, Chabbert-Buffet N et al. Collège National des Gynécologues et Obstétriciens Francais. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol 2010; 152: 133-137
• 5 National Collaborating Centre for Women’s and Children’s Health. Heavy menstrual bleeding. In: The National Institute for Health and Clinical Excellence Hrsg. Clinical Guideline. London: Royal College of Obstetricians and Gynaecologists; 2007
• 6 Matteson KA, Anderson BL, Pinto SB et al. Practice patterns and attitudes about treating abnormal uterine bleeding: a national survey of obstetricians and gynecologists. Am J Obstet Gynecol 2011; [in press]
• 7 Arena S, Zupi E. Heavy menstrual bleeding: considering the most effective treatment option. Women’s Health 2011; 7: 143-146
• 8 Roberts TE, Tsourapas A, Middleton LJ et al. Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis. Br Med J 2011; 342: d2202-d2202
• 9 Stang A, Merrill RM, Kuss O. Hysterektomien in Deutschland. Dtsch Ärztebl 2011; 108: 508-514
• 10 Müller A, Thiel FC, Renner SP et al. Hysterectomy – a comparison of approaches. Dtsch Ärztebl Internat 2010; 107: 353-359
• 11 Lethaby A, Irvine GA, Cameron IT. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database of Systematic Reviews. Issue 2008 1. CD001016
• 12 Hickey M, Higham JM, Fraser I. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation. Cochrane Database of Systematic Reviews; 2007 Issue 4. CD001895
• 13 Lethaby A, Cooke I, Rees MC. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database of Systematic Reviews; 2005 Issue 4. CD002126
• 14 Beaumont HH, Augood C, Duckitt K et al. Danazol for heavy menstrual bleeding. Cochrane Database of Systematic Reviews; 2007 Issue 3. CD001017
• 15 Farquhar C, Brown J. Oral contraceptive pill for heavy menstrual bleeding. Cochrane Database of Systematic Reviews; 2009 Issue 4. CD000154
• 16 Lethaby A, Augood C, Duckitt K et al. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database of Systematic Reviews; 2007 Issue 4. CD000400
• 17 Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Systematic Reviews; 2000 Issue 4. CD000249
• 18 Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database of Systematic Reviews; 2006 Issue 2. CD003855
• 19 Lethaby A, Shepperd S, Farquhar C et al. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database of Systematic Reviews; 1999 Issue 2. CD000329
• 20 Lethaby A, Hickey M, Garry R et al. Endometrial resection/ablation techniques for heavy menstrual bleeding. Cochrane Database of Systematic Reviews; 2009 Issue 4. CD001501
• 21 Sowter MC, Lethaby A, Singla AA. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding. Cochrane Database of Systematic Reviews; 2002 Issue 3. CD001124
• 22 Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie e. V. (AGO). Therapie der Vorstufen des Endometriumkarzinoms. In: Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie e. V. in der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. sowie in der Deutschen Krebsgesellschaft e. V. Hrsg. Leitlinien zum Zervixkarzinom, zum Endometriumkarzinom und zu den Trophoblasttumoren. München, Wien, New York: W. Zuckschwerdt Verlag; 2008: 88-89
• 23 Wiegratz I, Thaler CJ. Hormonale Kontrazeption – was, wann, für wen?. Dtsch Ärztebl 2011; 108: 495-505
• 24 Emons G, Kiesel L, Runnebaum I et al. Kommentar der Kommission Uterus der AGO zum Konsensuspapier des 3. radiologisch-gynäkologischen Expertentreffens zur Behandlung von Uterusmyomen durch Uterusarterienembolisation (UAE) in München, 15. Januar 2010.. Fortschr Röntgenstr 2010; 182: 1016-1017